AISRF Round 13 | COVID-19 Collaborative Research Projects

Australia India Strategic Research Fund (AISRF)

Australia India Strategic Research Fund (AISRF)

What is the Australia India Strategic Research Fund (AISRF)?

The Australia-India Strategic Research Fund (AISRF) is a grant opportunity to support collaborative research projects between Australia and India.



The Australia-India Strategic Research Fund (AISRF) provides grants for collaborative research projects with Indian partners. For Round 13 of the AISRF, your project must involve research in a COVID-19 focused priority area and must be mutually beneficial for Australia and India with outcomes that contribute to the global response to the COVID-19 pandemic.

The objectives of the AISRF program are to:

  • increase the uptake of leading science and technology by supporting collaboration between Australian and Indian researchers in strategically focused, leading-edge scientific research and technology projects
  • strengthen strategic alliances between Australian and Indian researchers, and
  • facilitate Australia and India’s access to the global science and technology system.

The objective AISRF Round 13 is to fund short collaborative research projects with tangible outcomes focused on responding to the COVID-19 pandemic.

The intended outcomes of the grant opportunity are:

  • bring together leading research institutions and/or industry in both Australia and India currently working on areas relevant to COVID-19 such as vaccines, therapeutics, and diagnostics.
  • projects of a mutually beneficial nature whose outcomes contribute to the global response to the COVID-19 pandemic.



In 2018, the Australian Government announced a total of $10 million over four years for the program. For this grant opportunity, $3 million is available over two years from 2020-21 to 2021-22.

The grant amount will be up to 100 per cent of eligible project expenditure (grant percentage).

  • the minimum grant amount is $300,000
  • the maximum grant amount is $600,000
  • the maximum project period is up to twelve months

You cannot use funding from other Commonwealth, State, Territory or local government grants to fund the balance of project expenditure not covered by the grant.


Priority Areas

Your project must be in a priority area. The priority areas for Round 13 – COVID 19 Collaborative Research Projects are:

Indo-Australian Science & Technology Fund (administered by DST in India)

  • Antiviral coatings, other preventive technologies
  • Data analytics, modelling, Artificial Intelligence applications
  • Screening and diagnostic testing

Indo-Australian Biotechnology Fund (administered by DBT in India)

  • Development of immunotherapeutics
  • Development of animal model/ in vitro model for vaccine development
  • Assay development and validation for testing of vaccines and therapeutics
  • Viral genomics and bioinformatics



To be eligible you must:

  • have an Australian business number (ABN)

and be one of the following entities:

  • a publicly funded research organisation (PFRO) as defined in section 14 of the grant opportunity guidelines
  • a Cooperative Research Centre (CRC)
  • an Australian State/Territory Government agency or body

Additionally, the program can only accept applications that have a primary Indian partner who has submitted, or is in the process of submitting, a corresponding application to India’s DST or DBT.

Joint applications involving more than one Australian partner are acceptable and industry involvement (including businesses) is encouraged where appropriate, provided the lead applicant is the main driver of the project and eligible to apply.



Applications close 02 July 2020.


More Information


Latest News

03 February 2021 – QUT awarded grant for COVID-19 surface research

Leading researchers from QUT and Metro North Hospital and Health Service have been awarded more than $500,000 from the Australia-India Strategic Research Fund to assist with their work into virus reduction from surfaces.

The grant, which will fund research into ways of killing viruses such as COVID-19 on surfaces with a wet-etching technique, was awarded to QUT’s Professor Prasad Yarlagadda in partnership with Metro North Hospital and Health Service’s Professor Michael Schuetz and Associate Prof Kaushik Chatterjee from the Indian Institute of Science, Bangalore.


Leave a Comment

Your email address will not be published.

Scroll to Top